The clinical trial involving 251
pediatric patients proved the efficacy of the syrup administered within the
first 24 hours of the onset of symptoms
The trial confirmed that using Bimunal:
shortens
the duration of viral respiratory infection
significantly
reduces symptoms of viral infections
reduces
the number of secondary bacterial infections
Rhinorrhea
Virus treatment in children using Bimunal
Rhinorrhea was reduced on the
first day already in a group of children who were using the syrup, Bimunal, to
boost their immunity and suppress the virus. After five days, nearly 30% of the
children had a lesser symptom of rhinorrhea than children in the group which did
not use the syrup. By the tenth day, the symptom of a runny nose was reduced in
90% of the children in the group which was using Bimunal. Overall, there were 3
times fewer children who still had a symptom of rhinorrhea in the group of
children who were using the syrup compared to the group of children who were
not using the syrup.
Treatment of sore throat using Bimunal
Sore throat was present as a symptom in all children who were tested during
the clinical trial. The children who received Bimunal as therapy began to feel
relief from the very first days. On the fifth day, more than half of the
children in the group of children who were not using Bimunal still had sore
throats, and in the group of children who were using the syrup, there were only
about 20% compared to their number at the onset of the viral infection. On the
tenth day, children who were using Bimunal almost had no sore throat at all,
while a quarter of children who were not using it were still in pain. The
percentage of the reduction of symptoms by using the syrup was even 97%.
Cough in children – How can Bimunal help you?
Cough is probably the most
persistent symptom compared to the other symptoms of respiratory infections. Sometimes
it even lasts a couple of weeks. As the examinations during the clinical trial
showed, Bimunal influenced its reduction as well. The number of children coughing
in the group of children who were taking Bimunal was 30% lower on the fifth day
compared to the other group. On the tenth day, 2,4 times fewer children were
coughing, thus a reduction of 70% was observed.
High fever in children and Bimunal
High fever was also reduced more
rapidly in the group of children who were using Bimunal.
It was recorded in the group of children who were using the syrup that all
children who had a fever at the onset of the viral infection on the day five no
longer had it. In the control group, the temperature was lower on the fifth
day, but it was still not in the normal range. The decrease in body temperature
was statistically significantly higher in children who were treated with
Bimunal, 1.03 ° C compared to 0.5 ° C in the control group.
The use of antipyretics
The use of antipyretics
(paracetamol and brufen) was observed in a significantly lower percentage in
the group of children who were using Bimunal since the first day of the viral
infection. On the first day in this group, antipyretics were less used for 15%,
and on the fifth day, their usage was two times less than in the control group.
Although antipyretics were used more in the control group, the body temperature
in children was higher.
Application of local vasoconstrictors, antihistamines, and antitussives
The use of local
vasoconstrictors, antihistamines, and antitussives, or different nasal drops,
was already 26% lower in the group of children who were using Bimunal from the
first day of the onset of the viral infection. For the first five days, they
were administered even 4x less in the group of children who were using Bimunal compared
to the control group. By the tenth day, this therapy was almost completely disregarded.
During the
study, the patients were examined three times – at the beginning of the
disease, on the fifth day, and after ten days. The examination included
demographic information, weight and height, medical history, physical
examination, and laboratory analysis for parameters: sedimentation, blood
count, CPR. The first group of children was using Bimunal from day one, and the
second (control) group was not using it at all.
An open-label multicenter clinical trial:
Prof. Dr Branimir Nestorović, moderator
Prof. Dr Kristina Mironska, co-moderator
Dr sci. med Katarina Milošević, research associate, co-moderator
Eucalyptus, mint and lavender - a recognizable and favourite combination in Spiranto inhalation patch can now be found in pharmacies under a new name - Respiratol.
Before it was traditionally used to treat coughs, colds, upper respiratory tract irritations and other diseases, pelargonium had been used for centuries in its original homeland of Africa as an ingredient in many natural remedies. Find out why pelargonium is a natural antibiotic.
